Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...
An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.
Lassa fever remains a major health challenge in Nigeria, killing 100 people in early 2025. What’s going wrong?
A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun ...
The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a decline in new confirmed Lassa fever cases across ...
Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the ...
NIH-sponsored trial of candidate vaccine to prevent Lassa fever begins enrolling participants: Bethesda, Maryland Thursday, March 20, 2025, 18:00 Hrs [IST] A National Institutes o ...
Renowned Nigerian physician, Dr. Tochi Okwor, said that the 2018 Lassa fever outbreak exposed critical gaps in the nation’s infection ...
A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun ...
This underscores the urgent need for better protective measures, adequate supply of personal protective equipment (PPEs), and ...
3d
News-Medical.Net on MSNClinical trial of vaccine candidate to prevent Lassa fever begins enrollmentA (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results